Attorney Brent R. Baker has been appointed to the board of directors of the American MedChem Nonprofit Corporation. Their mission is to discover, develop, and provide targeted medicines to treat rare and neglected diseases, particularly those of children.
Mr. Baker is an attorney at Clyde Snow & Sessions and a member of the Securities, Government and Corporate Investigations Enforcement and White Collar Crime Practice Group. He received his law degree from the University of Oregon School of Law, and a B.A. from the University of Utah. Mr. Baker has been listed among the Utah Legal Elite and Mountain States Super Lawyers as well as serving two terms as Commissioner on the Utah Securities Commission.